Food and Drug Administration Approval Summary: Odevixibat (Bylvay) for the Treatment of Pruritus With Progressive Familial Intrahepatic Cholestasis

SoJeong Yi, Ruby Mehta, Rebecca Hager et al.|Gastro Hep Advances|2024

Cited by 6